0001654954-22-012673.txt : 20220919
0001654954-22-012673.hdr.sgml : 20220919
20220919161625
ACCESSION NUMBER: 0001654954-22-012673
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220914
FILED AS OF DATE: 20220919
DATE AS OF CHANGE: 20220919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maggiore Christopher D.
CENTRAL INDEX KEY: 0001436075
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40449
FILM NUMBER: 221250792
MAIL ADDRESS:
STREET 1: 4788 NOBLES POND DR. NW
CITY: CANTON
STATE: OH
ZIP: 44718
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zivo Bioscience, Inc.
CENTRAL INDEX KEY: 0001101026
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870699977
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 E. LONG LAKE ROAD
STREET 2: SUITE 100
CITY: BLOOMFIELD HILLS
STATE: MI
ZIP: 48304
BUSINESS PHONE: (248) 452 9866
MAIL ADDRESS:
STREET 1: 21 E. LONG LAKE ROAD
STREET 2: SUITE 100
CITY: BLOOMFIELD HILLS
STATE: MI
ZIP: 48304
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTH ENHANCEMENT PRODUCTS INC
DATE OF NAME CHANGE: 20040202
FORMER COMPANY:
FORMER CONFORMED NAME: WESTERN GLORY HOLE INC
DATE OF NAME CHANGE: 19991215
4
1
section16.xml
FORM 4
X0306
4
2022-09-14
0001101026
Zivo Bioscience, Inc.
ZIVO
0001436075
Maggiore Christopher D.
4788 NOBLES POND DR. NW
CANTON
OH
44718
true
true
Common Stock
2022-09-14
4
P
false
5200
3.5281
A
808305
D
Common Stock
2022-09-14
4
P
false
2000
3.5507
A
810305
D
The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.45 to $3.7257 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.435 to $3.93 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Christopher D. Maggiore
2022-09-19